FDA Investigator Janet A Rajan

Janet A Rajan has conducted inspections on 24 sites in 2 countries as of 22 Apr 2024. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
24
Last Inspection Date:
22 Apr 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America, India
FDA Investigators that have inspected at least one site in common with Janet A Rajan:
Addam S Reynolds, Adetutu M Gidado, Alberto A Viciedo, Alison N Stieg, Amit Kokate, Amy L Singer, Anastasia I Onuorah, Ankur C Patel, Annemarie B Randow, Annemarie Bodnar, Annet R Rajan, Anthony F Lorenzo, Anthony W Lee, Atul J Agrawal, Barbara J Maulfair, Barbara Jwilimczyk Macri, Benton M Ketron, Brooke K Higgins, Brooke K Seeman, Bryan L Mcguckin, Carol L Rehkopf, Carole L Jones, Carolyn E Becker, Cassandra L Abellard, CDR Ileana Barreto Pettit, Chaltu Nwakijra, Charisse K Green, Charles J Chacko, Christina K Theodorou, Daniel J Grabicki, Daniel J Min, Daniel L Zheng, David A Oluwo, Dawn L Wydner, Demitria J Xiradakis, Dennis L Doupnik, Derek S Smith, PhD, Diane T Bargo, Diane T O'brien, Douglas A Campbell, Douglas C Kovacs, Emest F Bizjak, Emmanuel Jramos Maldonado, Ephrem Hunde, PhD, Felix Maldonado, Frederick F Razzaghi, Gerald B Seaborn, Jr, Gianine E Tompkins, Gregson A Joseph, Guerlain Ulysse, Haitao Li, Hala L Selby, Helen B Ricalde, Helen Verdel, Himanshu Gupta, PhD, Hongna Wang, James M Mason, James R Birkenstamm, James W Leonette, Jenny Sung, Jessica Hankins, PhD, Jessica S Estriplet, Jill J Tillman, Jogy George, John P Mistler, Johnna L Bleem, Jonah S Ufferfilge, Jonathan S Helfgott, Jonathan W Chapman, Jose Acruz Gonzalez, Jose M Cayuela, Joy Rkozlowski Klena, Juanita P Versace, Junho Pak, Justine Tomasso, Karen E D'orazio, Karen L Kosar, Karishma G Gopaul, Katelyn Astaub Zamperini, Kathleen M Jordan, Kelli F Dobilas, Kellie Leveille, Kelly L Anderson, Kenneth Nieves, Kevin A Gonzalez, Ko U Min, Krishnaiah Yellela, Kristy A Zielny, Kshitij A Patkar, Laishan L Lam, Lata C Mathew, PhD, Lauren L Vajo, Lawrence J Stringer, LCDR Debra Emerson, Li Li, Liatte Kreuger, PharmD, Lisa L Flores, Loretta Nemchik, Lori S Lawless, Louis G An, Malgorzata G Norton, PhD, Marcellinus D Dordunoo, Marcus A Ray, Maria Manzoni, PhD, Marion Michaelis, Masfin Abdi, Massoud Motamed, Matthew A Spataro, Mayar M Mussa, Melissa J Garcia, Melissa T Roy, Merideth K Rose, Meyer J Slobotsky, Michael J Vardon, Michael L Casner, Michael Levin, Michael R Dominick, Michael R Klapal, Michael Serrano, Michelle Marsh, Mindy M Chou, Monika Borkowska, Monique Rac Lester, Nancy F Scheraga, Nancy L Rolli, Nancy M Espinal, Nebil A Oumer, Neda Hamandi, Nerizza B Guerin, Nicholas A Violand, Nicole K Trudel, Niketa Patel, Patricia F Hughes, PhD, Patrick C Klotzbuecher, Paul L Bellamy, Paul Mouris, Paula J Bretz, Perry T Nichols, Peter R Lenahan, Philip F Istafanos, DMV, MS, Prabhu P Raju, Pratik S Upadhyay, DDC, Qin Xu, Quyen T Tran, Rabin N Ghoshal, Rachel C Harrington, Rebecca E Dombrowski, Regina Gibson Melton, Regina T Brown, Robert J Martin, Robin P Mathew, Rose Ljean Mary, Ruben C Quintana, Russell J Glapion, Saleem A Akhtar, Samir C Gala, Samuel T Walker, Sandra A Boyd, Sandra D Thompson, Satheesh K Podaralla, Sean R Marcsisin, Sena G Dissmeyer, Shahla Parvizi, Shirley S Wen, Simone E Pitts, Sinai I Davis, Sneha S Patel, Sony Mathews, Srinivas R Chennamaneni, PhD, Stacie A Woods, Stephen J Mottola, Stephenie M Ortiz, Steven P Donald, Suchan Kim, Susan M Jackson, Tamika White, Tamil Arasu, PhD, Tara K Carmody, Thomas J Arista, Tomika Crafter, Tomika L Crafter, Tonia F Bernard, Toyin B Oladimeji, Unnee Ranjan, Victoria Spivak, Walter L Fava, William A Warnick, William H Linkroum, William L Bargo, Yvesna C Blaise, Yvins Dezan, Zakaria I Ganiyu

Janet A Rajan's Documents

Publish Date Document Type Title
July, 2023 EIR Garonit Pharmaceutical, Inc. - EIR, 2023-07-20
May, 2022 FDA 483 Mylan Pharmaceuticals Inc. - Form 483, 2022-06-22
June, 2021 FDA 483 Carnegie Pharmaceuticals, LLC - Form 483, 2021-06-29
February, 2022 EIR Strides Pharma, Inc - EIR, 2022-02-08
July, 2023 FDA 483 Garonit Pharmaceutical, Inc. - Form 483, 2023-07-06
May, 2022 FDA 483 Ferring Production Inc. - Form 483, 2022-05-12
April, 2024 FDA 483 Imprimis NJOF, LLC - Form 483, 2024-04-03
January, 2021 FDA 483 Imprimis NJOF, LLC - Form 483, 2021-01-29
November, 2021 FDA 483 Ideal Specialty Apothecary, Inc. dba Ideal Pharmacy - Form 483, 2021-11-18
May, 2021 FDA 483 SAMJAN GROUP INC. (DBA PLS Analytical) - Form 483, 2021-05-28
January, 2023 FDA 483 Novel Laboratories, Inc. - Form 483, 2023-01-13
February, 2022 FDA 483 Strides Pharma, Inc - Form 483, 2022-02-08
March, 2023 FDA 483 I 3 PHARMACEUTICALS, LLC - Form 483, 2023-03-03
September, 2023 FDA 483 CURIA NEW JERSEY LLC - Form 483, 2023-09-21
October, 2022 FDA 483 QuVa Pharma, Inc. - Form 483, 2022-10-14
March, 2022 FDA 483 SAMJAN GROUP INC. (DBA PLS Analytical) - Form 483, 2022-03-03
November, 2021 FDA 483 Response Ideal Specialty Apothecary, Inc. dba Ideal Pharmacy - Form 483R, 2021-11-18
May, 2024 FDA 483 United Therapeutics Corporation - Form 483, 2024-05-02
August, 2023 FDA 483 Cangene BioPharma, LLC - Form 483, 2023-08-10
August, 2024 FDA 483 API, Inc. - Form 483, 2024-08-08
September, 2024 FDA 483 Accupac, LLC - Form 483, 2024-09-13

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more